Evidence Intelligence Updates
Follow QSevidence product progress, MedClaw workflows, medical AI infrastructure, digital health milestones and official company updates.
At the 4th China AIGC Industry Summit, Qingsong Health received enterprise-level recognition for AI and health innovation, while QSevidence was selected as a notable AIGC product in medical AI.
Read UpdateThe appointment recognizes Qingsong Health's capabilities across digital health services, AI medical innovation, pharmaceutical collaboration and industry ecosystem development.
Read UpdateThe collaboration focuses on high-quality medical data resources, evidence-based medicine and large-model technology to strengthen traceability, transparency and compliance for medical AI.
Read Update
Chairwoman and CEO Yang Yin called for evidence-based AI to help turn health anxiety into clearer judgment, professional information into action paths and episodic care into continuous management.
Read Update
Qingsong Health presented QSevidence MedClaw and its early-disease screening portfolio at the 2026 World Internet Conference Asia-Pacific Summit in Hong Kong.
Read Update
The first release introduced 886 standardized skills across clinical diagnosis and treatment, public health, imaging, laboratory medicine, hospital management, nursing, medical records and medication management.
Read Update
The MedClaw collaboration body combines evidence retrieval, guideline comparison, credibility grading, task planning, content generation and process records into one traceable workflow.
Read Update